SurgiMab is a company that develops a technology of intraoperative detection of tumors. It offers injectable fluorescent conjugates to be used during fluorescence-guided surgery (FGS) by oncology surgeons to delineate tumors and visualize infra-clinical size nodules invisible to the naked eye. The technology of fluorescence imaging can also be used for cancer staging and detection of metastases that are too small to be detected.